The Business Research Company published its Autoimmune Disease Diagnosis Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Autoimmune Disease Diagnosis market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the Autoimmune Disease Diagnosis market’s segments-
1) By Product: Consumables & Assay Kits, Instruments
2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
3) By End User: Clinical Laboratories, Hospitals, Other End Users.
View Complete Report:
Autoimmune Disease Diagnosis Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global autoimmune disease diagnosis market is expected to decline from $3.58 billion in 2019 to $3.08 billion in 2020 at a compound annual growth rate (CAGR) of -13.99%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $4.55 billion in 2023 at a CAGR of 13.96%.
Biosensors and nano biosensors for rapid detection is a novel tool for the detection of antibodies in the autoimmune disease diagnosis market. They are highly preferred because of low cost, high sensitivity, simple to use, multiplexing abilities and rapid diagnosis. Besides measuring the quantity of antibodies in human blood serum with extremely high sensitivity, it also quantifies the activity of antibodies as the assay employs portable optical label-free biosensors based on the spectral correlation interferometry. This point of care technology gives a more integrated, informative, timely and precise diagnosis of autoimmune diseases when compared to the conventional ones.
Few Points From The Table Of Contents
1. Executive Summary
2. Autoimmune Disease Diagnosis Market Characteristics
3. Autoimmune Disease Diagnosis Market Size And Growth
4. Autoimmune Disease Diagnosis Market Segmentation
5. Autoimmune Disease Diagnosis Market Regional And Country Analysis
25. Autoimmune Disease Diagnosis Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Autoimmune Disease Diagnosis Market
27. Autoimmune Disease Diagnosis Market Trends And Strategies
28. Autoimmune Disease Diagnosis Market Future Outlook and Potential Analysis
Request For A Sample Report At:
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 46: Thermo Fisher Scientific Financial Performance
Table 47: Siemens Healthineers Financial Performance
Table 48: Abbott Financial Performance
Table 49: Danaher Financial Performance
Table 50: Bio-Rad Laboratories Financial Performance
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on Blog: http://blog.tbrc.info/
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company